In the third quarter, Cullen Frost Bankers Inc. trimmed its position in Union Pacific Corporation by 34.0%, selling 59,023 shares and reducing its holdings to 114,811 shares. As of the most recent Form 13F filing, this stake was valued at $27.14 million. This reduction contrasts with several new institutional entrants into UNP, including Howard Hughes Medical Institute and Total Investment Management Inc., which each initiated positions worth approximately $30,000 in the second quarter. Overall, institutional and hedge fund ownership remains robust at 80.38% of the float.

Union Pacific reported third-quarter EPS of $3.08, surpassing the consensus estimate of $2.99 by $0.09. Revenue came in at $6.24 billion, in line with forecasts and marking a 2.5% year-over-year increase. Profitability metrics were strong, with a net margin of 28.73% and a return on equity of 42.23%. The company’s debt-to-equity ratio stood at 1.75, while liquidity ratios included a current ratio of 0.75 and a quick ratio of 0.60.

On December 30th, Union Pacific paid its quarterly dividend of $1.38 per share, equivalent to a $5.52 annualized payout and a 2.4% yield, with a payout ratio of 46.9%. Analysts maintain a moderate buy consensus: of 24 covering firms, one rates UNP as Strong Buy, twelve as Buy and eleven as Hold, with an average price target of $258.18 and recent targets ranging from $245.00 to $285.00.